Osteosarcoma tumor tissue of the first vaccination study (study I) was stained for the vascular marker CD31 to determine the effect of vaccination against CD99 on the tumor vasculature (Figure 2E, upper panels). This evidence concerns the gene CD99 and neoplasm.